Approximately 14 states cover GLP-1 medications for weight loss as of 2025, typically with extensive prior authorization requirements
COA is published on the product page and verifiable at verify.janoshik.com
In the United States, oral and injectable forms of SMG are approved for treating T2DM, while only injectable forms are approved for treating obesity (103)
As evident, both liraglutide and retatrutide can induce significant weight loss
With a wide range of whitening skincare products that claim to deliver positive results within X number of days, how can you be a wise consumer to ensure that a product contains the right ingredients to effect its claims over a period of time
As an MC1R agonist, MT1 facilitates melanin production, leading to a darker skin tone with repeated administration